Name of organisation
1) Department/Research groupCEDOC - Chronic Diseases Research Center of the Faculdade de Ciências Médicas da Universidade Nova de Lisboa
2) Organisation/affiliationFaculdade Ciências Médicas Univ. Nova Lisboa
Short Name in the inventoryCEDOC/FCM-UNL
Administrative Contact
Title Dr
Last name Carapuço
First name Marta
Address line 1Rua Câmara Pestana nº 6
Address line 2Edifício CEDOC II – Edifício cinzento, 2ºpiso, sala 2.2.
Address line 3
CityLisbon
Postcode1150-082
CountryPortugal
Phone number (incl. country code)00351218803101
Alternative phone number00351218803103
Fax number (incl. country code)
Scientific Contact
Title Professor
Last name Jacinto
First name António
Address line 1CEDOC at IGC Research Center
Address line 2Rua da Quinta Grande, nº 6
Address line 3
CityOeiras
Postcode2780-156
CountryPortugal
Phone number (incl. country code)00351211157705
Alternative phone number
Fax number (incl. country code)
Alternative Scientific Contact
Title Professor
Last name Caetano
First name Pedro
Address line 1GIAI - Grupo de Informação Académica Independente
Address line 2CEDOC da Faculdade de Ciências Médicas - UNL
Address line 3Rua Câmara Pestana n.º 6, Edificio Amarelo, room 2.20 (phone extension 27003)
CityLisbon
Postcode1150-082
CountryPortugal
Phone number (incl. country code)00351218803101
Alternative phone number
Fax number (incl. country code)
2. Description
CEDOC from FCM-UNL brings together biomedical, translational & clinical research, and hosts 30 groups and nearly 200 Academics & Clinicians researchers (the majority holding appointments at the School of Medicine or in 10 Hospitals in the Great Lisbon Area). CEDOC joined the Associate Laboratory (2011), a research consortium that ranks top in the Portuguese government evaluations, allowing researchers to state of the art technology & science. CEDOC started with and is strong in molecular biology with articles published in nature and science. Recently, CEDOC has been developing capabilities in pharmacoepidemiology, through GIAI, the Group for Independent Academic Information. GIAI is a partnership between the family practice & pharmacology depts. GIAI aims to close the gap between pharmacoepidemiology evidence & clinical prescribing. In collaboration with the Department of Pharmacoepidemiology of Harvard Medical School, GIAI has produced Prescribing guidelines and evaluates its effects.
3. Category
University based
R&D Institution
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
No
Statistician
Yes
Yes
Clinician
Yes
Yes
Clinical Pharmacologist
Yes
No
Pharmacist
Yes
No
Geneticist/Pharmacogeneticist
Yes
No
Ethics expertise
Yes
No
Legal expertise
Yes
No
Regulatory expertise
Yes
Yes
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Congenital Malformations
Disorders of the central nervous system
Ear, nose and oropharynx disorders
Endocrine disorders
Eye disorders
Gastrointestinal tract
Geriatrics
Gynaecology
Immunological products and vaccines
Immunosuppression
Infectious diseases
Liver disease
Malignant disease
Musculoskeletal and joint diseases
Neonates
Nutrition and blood
Osteoporosis
Poisoning/Overdose
Psychiatry
Respiratory diseases
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
Interventional Clinical Trial
Meta-Analysis
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Greater than 5
Number of patients/respondents involved in the study(ies)
Between 1500 and 14999
8. Access to data collection resources
Capacity to conduct face-to-face interviews
Yes
In a clinic
Yes
In the community
Yes
Electronic data capture systems
Yes
System used:
CRF Electronic
Interactive voice response systems
No
Call centre
No